Ken Griffin Pasithea Therapeutics Corp Wt Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pasithea Therapeutics Corp Wt stock. As of the latest transaction made, Citadel Advisors LLC holds 13,189 shares of KTTAW stock, worth $263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,189
Previous 13,204
0.11%
Holding current value
$263
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KTTAW
# of Institutions
6Shares Held
661KCall Options Held
0Put Options Held
0-
Kepos Capital LP New York, NY335KShares$6,6920.01% of portfolio
-
Warberg Asset Management LLC Winnetka, IL263KShares$5,2600.06% of portfolio
-
Armistice Capital, LLC New York, NY50KShares$1,0000.0% of portfolio
-
Ubs Group Ag34Shares$00.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About PASITHEA THERAPEUTICS CORP WT
- Ticker KTTAW
- Sector Healthcare
- Industry Biotechnology